The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis

Digestive and Liver Disease

Volumn 43, Issue 3, 2011, Pages 194-198

  Scartozzi, Mario ^a   Siquini, Walter ^a   Galizia, Eva ^a   Stortoni, Pierpaolo ^b   Marmorale, Cristina ^a   Berardi, Rossana ^a   Fianchini, Aroldo ^a   Cascinu, Stefano ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Oncologia Medica Ospedale ' E Profili'   (Italy)

Author keywords

Colorectal cancer; Liver metastases; Neoadjuvant chemotherapy; Surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79551471126     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.07.003     Document Type: Article

References (22)

1. Kemeny N., Fata F. Arterial, portal or systemic chemotherapy for patients with hepatic metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999, 6:39-49.
2. Seifert J.K., Junginger T., Morris D.L. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edin 1998, 43:141-144.
3. Stangl R., Altendorf-Hofmann A., Charnley R.M., et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994, 343:1405-1410.
4. Douillard J.Y., Cunningham D., Roth A.D., et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000, 355:1041-1047.
5. de Gramont A., Figer A., Seymour M., et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18:2938-2947.
6. Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004, 22:229-237.
7. Cunningham D., Humblet Y., Siena S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004, 351:337-345.
8. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
9. Vadeyar H.J. Current therapeutic options for colorectal liver metastases. Indian J Gastroenterol 2007, 26:26-29.
10. Fong Y., Fortner J.G., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318.
11. Leonard G.D., Brenner B., Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005, 23:2038-2048.
12. Giacchetti S., Itzhaki M., Gruia G., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999, 10:663-669.
13. Bismuth H., Adam R., Lévi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996, 224:509-522.
14. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008, 371:1007-1016.
15. Petrelli N.J., Graham H.F. Perioperative or adjuvant therapy for resectable colorectal hepatic metastases. J Clin Oncol 2008, 26:4862-4863.
16. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990, 77:1241-1246.
17. Chong G., Cunningham D. Improving long-term outcomes for patients with liver metastases from colorectal cancer. J Clin Oncol 2005, 23:9063-9066.
18. Ellis L.M., Curley S.A., Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 2005, 23:4853-4855.
19. Leichman L. Neoadjuvant chemotherapy for disseminated colorectal cancer: changing the paradigm. J Clin Oncol 2006, 24:3817-3818.
20. Wang X., Hershman D.L., Abrams J.A., et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer 2007, 97:1606-1612.
21. Kemeny N. Presurgical chemotherapy in patients being considered for liver resection. Oncologist 2007, 12:825-839.
22. Benoist S., Brouquet A., Penna C., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 2006, 24:3939-3945.